HK1127917A1 - Imidazo [1,2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands - Google Patents

Imidazo [1,2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands

Info

Publication number
HK1127917A1
HK1127917A1 HK09104968.1A HK09104968A HK1127917A1 HK 1127917 A1 HK1127917 A1 HK 1127917A1 HK 09104968 A HK09104968 A HK 09104968A HK 1127917 A1 HK1127917 A1 HK 1127917A1
Authority
HK
Hong Kong
Prior art keywords
pyridazines
imidazo
processes
preparation
receptor ligands
Prior art date
Application number
HK09104968.1A
Other languages
English (en)
Inventor
Jose Luis Falco
Albert Palomer
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of HK1127917A1 publication Critical patent/HK1127917A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK09104968.1A 2006-03-29 2009-06-03 Imidazo [1,2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands HK1127917A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06111899A EP1845098A1 (fr) 2006-03-29 2006-03-29 Imidazo[1,2-b]pyridazines, leur procédés de préparation et leur utilisation comme ligands du recepteur GABA
PCT/EP2007/052988 WO2007110437A1 (fr) 2006-03-29 2007-03-28 Imidazo [1, 2-b] pyridazines, leurs procédés de préparation et leur utilisation en tant que ligands du récepteur gaba

Publications (1)

Publication Number Publication Date
HK1127917A1 true HK1127917A1 (en) 2009-10-09

Family

ID=36323447

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104968.1A HK1127917A1 (en) 2006-03-29 2009-06-03 Imidazo [1,2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands

Country Status (23)

Country Link
US (2) US8153789B2 (fr)
EP (2) EP1845098A1 (fr)
JP (1) JP5091944B2 (fr)
KR (1) KR20090008275A (fr)
CN (1) CN101448831B (fr)
AR (1) AR060212A1 (fr)
AT (1) ATE471325T1 (fr)
AU (1) AU2007231362B2 (fr)
BR (1) BRPI0709207A2 (fr)
CA (1) CA2647116C (fr)
CY (1) CY1111211T1 (fr)
DE (1) DE602007007203D1 (fr)
DK (1) DK2010536T3 (fr)
ES (1) ES2347182T3 (fr)
HK (1) HK1127917A1 (fr)
MX (1) MX2008012274A (fr)
NO (1) NO20084375L (fr)
PL (1) PL2010536T3 (fr)
PT (1) PT2010536E (fr)
RU (1) RU2486188C9 (fr)
SI (1) SI2010536T1 (fr)
TW (1) TWI403512B (fr)
WO (2) WO2007110437A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713784A1 (fr) * 2004-02-12 2006-10-25 Neurogen Corporation Imidazo-pyridazines, triazolo-pyridazines et ligands associes des recepteurs de benzodiazepine
US8217177B2 (en) 2006-07-14 2012-07-10 Amgen Inc. Fused heterocyclic derivatives and methods of use
PE20080403A1 (es) 2006-07-14 2008-04-25 Amgen Inc Derivados heterociclicos fusionados y metodos de uso
US8198448B2 (en) 2006-07-14 2012-06-12 Amgen Inc. Fused heterocyclic derivatives and methods of use
FR2918061B1 (fr) * 2007-06-28 2010-10-22 Sanofi Aventis Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
WO2009057577A1 (fr) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. Utilisation d'un nouveau composé présentant une affinité pour les substances amyloïdes et procédé de production dudit composé
US7868001B2 (en) * 2007-11-02 2011-01-11 Hutchison Medipharma Enterprises Limited Cytokine inhibitors
WO2009079683A1 (fr) * 2007-12-21 2009-07-02 The University Of Sydney Ligands de la protéine de translocation
EP2103614A1 (fr) * 2008-03-18 2009-09-23 Santhera Pharmaceuticals (Schweiz) AG Dérivés d'imidazopyrimidine, d'imidazopyrazine et d' imidazopyridazine substitués en tant que modulateur de récepteur de la mélanocortine-4
JP5774982B2 (ja) * 2008-05-19 2015-09-09 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． イミダゾ［１，２−ａ］ピリジン化合物
CN102131801B (zh) * 2008-06-25 2015-04-08 福拉姆医药股份有限公司 1,2-二取代的杂环化合物
US20100267730A1 (en) * 2008-10-09 2010-10-21 Giuseppe Alvaro Novel compounds
CN102459242B (zh) 2009-05-07 2015-08-26 费瑞姆医药有限公司 苯氧基甲基杂环化合物
TWI617559B (zh) * 2010-12-22 2018-03-11 江蘇恆瑞醫藥股份有限公司 ２－芳基咪唑并［１，２－ｂ］嗒．２－苯基咪唑并［１，２－ａ］吡啶，和２－苯基咪唑并［１，２－ａ］吡衍生物
UA112028C2 (uk) * 2012-12-14 2016-07-11 Пфайзер Лімітед Похідні імідазопіридазину як модулятори гамка-рецептора
GB201321734D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
DE3542661A1 (de) * 1985-12-03 1987-06-04 Bayer Ag Imidazopyridazinalkensaeureamide, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung
DE8808030U1 (de) * 1987-07-04 1988-11-03 Krones Ag Hermann Kronseder Maschinenfabrik, 8402 Neutraubling Etikettiervorrichtung für Behälter
WO1989001333A1 (fr) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
AU7079998A (en) * 1997-04-25 1998-11-24 Takeda Chemical Industries Ltd. Condensed pyridazine derivatives, their production and use
WO1999036423A1 (fr) * 1998-01-14 1999-07-22 Merck Sharp & Dohme Limited Derives de triazolo-pyridazine utiles comme ligands des recepteurs gaba
CA2348022A1 (fr) * 1998-10-21 2000-04-27 Takeda Chemical Industries, Ltd. Derives fusionnes de pyridazine, leur preparation et utilisation
SK286788B6 (sk) * 1999-10-08 2009-05-07 Grnenthal Gmbh Bicyklické deriváty imidazo-3-yl-amínu, spôsob ich výroby, ich použitie a liečivá obsahujúce tieto látky
EP1243271A1 (fr) * 1999-11-11 2002-09-25 Takeda Chemical Industries, Ltd. Gouttes nasales contenant des derives de pyridazine condenses
JP2002371042A (ja) * 2001-06-12 2002-12-26 Takeda Chem Ind Ltd ジアミン化合物、その製造法および用途
ATE346070T1 (de) * 2002-03-05 2006-12-15 Lilly Co Eli Purinderivate als kinaseinhibitoren
GB0210124D0 (en) * 2002-05-02 2002-06-12 Merck Sharp & Dohme Therapeutic agents
US7385056B2 (en) * 2002-12-18 2008-06-10 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
CA2585315A1 (fr) * 2004-11-11 2006-05-18 Ferrer Internacional, S.A. Derives d'imidazo[1,2-a]pyridine, et preparations, emplois et methodes lies a ces derives
EP1848420A4 (fr) * 2005-01-28 2008-01-23 Merck & Co Inc Formes polymorphes d'un agoniste gabaa
EP1803722A1 (fr) * 2006-01-03 2007-07-04 Ferrer Internacional, S.A. Hydrazides d'acides imidazo[1,2-a]pyridin-3-yl-acétiques, leurs procédés de préparation et leur utilisation comme médicaments
JP2010508314A (ja) * 2006-10-30 2010-03-18 ノバルティス アーゲー 脂質キナーゼ阻害剤としてのイミダゾピリダジン

Also Published As

Publication number Publication date
EP2010536A1 (fr) 2009-01-07
BRPI0709207A2 (pt) 2011-06-28
US20120040979A1 (en) 2012-02-16
AU2007231362B2 (en) 2012-07-19
WO2007110438A1 (fr) 2007-10-04
ES2347182T3 (es) 2010-10-26
JP2009531384A (ja) 2009-09-03
MX2008012274A (es) 2008-11-12
PL2010536T3 (pl) 2010-11-30
WO2007110437A1 (fr) 2007-10-04
CA2647116A1 (fr) 2007-10-04
KR20090008275A (ko) 2009-01-21
EP1845098A1 (fr) 2007-10-17
JP5091944B2 (ja) 2012-12-05
DE602007007203D1 (de) 2010-07-29
PT2010536E (pt) 2010-09-03
TW200813062A (en) 2008-03-16
NO20084375L (no) 2008-10-17
SI2010536T1 (sl) 2010-10-29
EP2010536B1 (fr) 2010-06-16
US20090176788A1 (en) 2009-07-09
RU2008142841A (ru) 2010-05-10
ATE471325T1 (de) 2010-07-15
CN101448831A (zh) 2009-06-03
US8993562B2 (en) 2015-03-31
CN101448831B (zh) 2013-05-01
US8153789B2 (en) 2012-04-10
RU2486188C2 (ru) 2013-06-27
DK2010536T3 (da) 2010-10-04
AU2007231362A1 (en) 2007-10-04
TWI403512B (zh) 2013-08-01
CA2647116C (fr) 2013-12-31
AR060212A1 (es) 2008-06-04
RU2486188C9 (ru) 2013-08-10
CY1111211T1 (el) 2015-06-11

Similar Documents

Publication Publication Date Title
HK1127917A1 (en) Imidazo [1,2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands
ZA200909186B (en) 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives,preparation thereof and therapeutic use thereof
ZA201001214B (en) 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapuetic application thereof
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
ZA201004524B (en) Pyrido[2,3-b]pyrazine-8-substituted compounds and their use
EP2387315A4 (fr) Imidazo[1,2-a]pyridines et imidazo[1,2-b]pyridazines utilisés en tant qu'inhibiteurs de la kinase mark
IL194522A0 (en) Process for the preparation of prasugrel
IL193740A0 (en) PYRIDO [3, 2 - e] PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
IL201471A0 (en) Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
IL219424A0 (en) IMIDAZO [1,2-b] PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
IL201450A0 (en) Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
IL211141A0 (en) 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof, and therapeutic application thereof
IL206673A0 (en) Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application
PT2448940E (pt) Derivados de 6,7,8,9-tetra-hidro-pirimido{1,2-α} pirimidin- 4-ona, sua preparação e sua utilização farmacêutica
IL206671A0 (en) N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
IL197500A0 (en) Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
IL195949A0 (en) Use of derivatives of imidazo[1,2-a]pyridine-2-carboxamides in therapeutics
IL213581A0 (en) Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo [1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo [1,2-b]-pyridazine, preparation and therapeutic application thereof
IL213208A0 (en) 6-cycloamino-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
IL206669A0 (en) 6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
IL187441A0 (en) Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
ZA201004520B (en) N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds,preparation thereof and therapeutic application thereof
ZA200904148B (en) Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
SI2059521T1 (sl) Pirazolo alfa pirimidini postopki uporabe in sestavki
ZA201004641B (en) Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170328